Настройки

Укажите год
-

Небесная энциклопедия

Космические корабли и станции, автоматические КА и методы их проектирования, бортовые комплексы управления, системы и средства жизнеобеспечения, особенности технологии производства ракетно-космических систем

Подробнее
-

Мониторинг СМИ

Мониторинг СМИ и социальных сетей. Сканирование интернета, новостных сайтов, специализированных контентных площадок на базе мессенджеров. Гибкие настройки фильтров и первоначальных источников.

Подробнее

Форма поиска

Поддерживает ввод нескольких поисковых фраз (по одной на строку). При поиске обеспечивает поддержку морфологии русского и английского языка
Ведите корректный номера.
Ведите корректный номера.
Ведите корректный номера.
Ведите корректный номера.
Укажите год
Укажите год

Применить Всего найдено 3. Отображено 3.
18-08-2015 дата публикации

USE OF IP-10 FOR PREDIDICTING RAPID PROGRESS TO AIDS FOR EARLY HIV-1 INFECTED SUBJECTS

Номер: KR0101542510B1
Принадлежит: 대한민국

... 본 발명은 AIDS 질환의 급속한 진행 여부를, 초기 HIV-1 감염자의 혈장 내 IP-10 단백질 수준을 측정하여 예측 및/또는 진단하는 것을 제공한다. 또한, 본 발명에 따르면, 초기 HIV-1 감염자의 혈장 내 IP-10 단백질의 수준을 측정함으로써, 초기 HIV-1 감염자가 AIDS 환자로 급속히 진행하는 것을 억제하기 위한 약물을 스크리닝 하거나, 기존 약물의 효능을 모니터링 하는데 이용할 수도 있다.

Подробнее
23-07-2015 дата публикации

USE OF IP-10 FOR PREDICTING RAPID PROGRESS TO AIDS FOR EARLY HIV-1 INFECTED SUBJECT

Номер: KR1020150085239A
Принадлежит:

The present invention relates to a method for predicting or/and diagnosing a rapid progress to acquired immune deficiency syndrome (AIDS) disease by measuring the level of interferon gamma inducible protein-10 (IP-10) in a plasma of an early HIV-1 infected subject. In addition, according to the present invention, the level of the IP-10 in the plasm of an early HIV-1 infected subject is measured, thereby being used for screening drugs which inhibit an early HIV-1 infected subject from becoming an AIDS patient, or for monitoring efficacy of an existing drug. COPYRIGHT KIPO 2015 ...

Подробнее
14-02-2013 дата публикации

PHARMACEUTICAL COMPOSITION CONTAINING FIBULIN-3 PROTEIN AS AN ACTIVE INGREDIENT FOR INHIBITING THE GROWTH OF CANCER STEM CELLS

Номер: WO2013022157A1
Принадлежит:

The present invention relates to a pharmaceutical composition containing fibulin-3 protein as an active ingredient for inhibiting the growth of cancer stem cells. More particularly, in cancer stem cells which have been distinguished from H460 and A549, which are non-small-cell lung cancer cells, using ALDH1 activity as a marker, fibulin-3 induces the reduction of wnt/β-catenin and MMP2, 7, which display characteristics of cancer stem cells, thereby decreasing the activated growth and penetration of the cancer stem cells. In addition, purified fibulin-3 protein inhibits the growth of the non-small-cell lung cancer cell A549, the breast cancer cell MDA-MB231, and the cancer stem cell active ALDH1. Thus, fibulin-3 can be valuably used as an active ingredient in the pharmaceutical composition for inhibiting the growth of cancer stem cells.

Подробнее